This website provides information about the business field of CO.DON GmbH, which has taken over the business operations from CO.DON AG.
Information on CO.DON Aktiengesellschaft can be found at www.codon-aktiengesellschaft.de.
Management
The management of CO.DON GmbH is responsible for managing the company. It acts independently and is responsible for the company meeting the objectives laid down in its Rules of Procedure. To this end it takes the necessary entrepreneurial measures, i.e. decisions on staffing, finances and strategy. A team of division managers assists the management with the development and implementation of the company strategy.
YING ZHOU, PhD has been appointed as the Managing Director since June 2023.
Dr. Ying Zhou is a renowned leader with a Ph.D. in Biochemistry from Boston University, School of Medicine. With over a decade of experience in the pharmaceutical and bio-pharmaceutical industries, including roles at AstraZeneca, Ambergen, and Alkermes, she has made significant contributions to Drug Discovery and Development.
Dr. Zhou co-founded ReLive Biotechnology, a global regenerative medicine company group focused on cell therapies, orthopedics, and plastic & reconstructive surgery. This innovative venture operates in the United States, Europe, and China, with a mission to transform the field of tissue engineering and regenerative medicine. Under her visionary leadership, ReLive Biotechnology acquired all assets from CO.DON AG in January 2023, positioning the company as a front-runner in the industry. Driven by her passion for scientific advancement and her commitment to improve patient care, Dr. Zhou continues to pave the way for groundbreaking treatments that harness the body's natural regenerative capabilities, which could significantly improve the patients' quality of life.